Test Code HIAAP 5-Hydroxyindoleacetic Acid, Plasma
Ordering Guidance
This test quantifies 5-hydroxyindoleacetic acid in plasma specimens and is comparable to testing on 24-hour and random urine specimens for the diagnosis and monitoring of intestinal carcinoid syndrome.
Necessary Information
Patient's age is required.
Specimen Required
Patient Preparation:
1. Some medications could interfere with test results. The ordering provider should decide if any medications should be stopped and when they should be restarted. If clinically feasible, discontinue the following medications at least 24 hours prior to specimen collection:
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements.
2. For 24 hours prior to the collection, the patient should:
Limit the following to one serving per day:
-Fruits
-Vegetables
-Caffeinated beverages or foods
Abstain from the following:
-Nuts, especially walnuts. Plasma 5-hydroxyindoleacetic acid levels revert to baseline levels when walnuts are ingested after other foods.
Collection Container/Tube:
Preferred: Green top (sodium heparin)
Acceptable: Lavender top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Centrifuge at 4° C.
2. Aliquot plasma into plastic vial.
3. Send plasma frozen.
Secondary ID
619735Useful For
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using a plasma specimen
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Specimen Type
PlasmaSpecimen Minimum Volume
0.2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen (preferred) | 60 days | |
Refrigerated | 72 hours |
Reject Due To
Gross hemolysis | OK |
Thawing** | Cold OK; Warm reject |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
≤6 months: ≤130 ng/mL
>6 months: ≤30 ng/mL
Interpretation
If pharmacological and dietary artifacts have been ruled out, an elevated concentration of 5-hydroxyindoleacetic acid is a probable indicator of the presence of a serotonin-producing tumor.
Method Description
Plasma is mixed with deuterium labeled hydroxyindoleacetic acid (HIAA) as internal standard in acetonitrile. After centrifugation and filtration, the sample is reconstituted in mobile phase. Liquid chromatography tandem mass spectrometry is performed by injecting the reconstituted specimen onto a reverse phase high-performance liquid chromatography column. HIAA is quantitated using the stable isotope-labeled internal standard from calibration over a concentration range of 0 to 1000 ng/mL.(Unpublished Mayo method)
Day(s) Performed
Monday, Wednesday, Friday
Report Available
3 to 6 daysSpecimen Retention Time
1 monthPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
83497
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HIAAP | 5-Hydroxyindoleacetic Acid, P | 1693-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
619735 | 5-Hydroxyindoleacetic Acid, P | 1693-1 |